Astrazeneca (AZN)


AZN Share PerformanceMore

52 week high5,505.0 05/08/16
52 week low3,680.0 24/06/16
52 week change 315.5 (7.37%)
4 week volume70,066,340 24/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Unilever pushes FTSE higher on takeover approach by Kraft Heinz

Marmite owner Unilever (ULVR) rejected a 115bn takeover bid from US rival Kraft Heinz. Management said the offer un...

Sterling weakens as slow spending threatens UK retail sales

Sterling struggled following the publication of disappointing UK retail sales, while worldwide markets remained stagnant. ...

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC

Jefferies International today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price targ...

FTSE 100 down an ace on lenders, miners

London blue chips were down an ace in opening deals, but already rising off earlier lows, after key US and Asian indices s...

AZ reports positive results for Lynparza in cancer trial

AstraZeneca has announced positive results from its phase III OLYMPIAD trial comparing Lynparza (olaparib) tablets (30...

Lynparza positive in metastatic BRCA breast cancer

RNS Number: 1622X AstraZeneca PLC 17 February 2017 This announcement contains inside information 17 February 2017, 07:00 GMT LYNPARZA MEETS PRIMARY ENDPOINT IN PHASE III TRIAL IN BRCA -MUTATED METASTATIC BREAST CANCER Lynparza provided a statistically-significant improvement in progression-free survival compared to ch...

Trump-Russia links concern investors

Oil prices remained stagnant throughout the day, preventing sector giants Royal Dutch Shell (RDSB) and BP (BP.) from gi...

Neil Woodford’s seven trades in January

After a poor 2016, star fund manager Neil Woodford lagged the wider market again in January. He's also been bargain hu...

Latest discussion posts More

  • Re: share price drop

    Have you not heard? Under the mattress offers a yield of 10%, but don't tell write a block about it. It's our little secret. Also little know fact; if it's a king size double ...
  • Good news drug trials

    First of the new pipeline drugs, treatment for breast cancer, has positive trial results producing a significant effect. So let's hope that this is just the start of the new ...
  • Re: share price drop

    write a block, with all due respect please don't be such a pompous clot. The fact that Astrazeneca fell yesterday mostly, in all probability, because it went ex-dividend is ...

Users' HoldingsMore

Users who hold Astrazeneca also hold..
RDS 'B'33%

Codes & Symbols